Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
Colin S Tan,1,2 SriniVas R Sadda3 1National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; 2Fundus Image Reading Center, National Healthcare Group Eye Institute, Singapore; 3Doheny Eye Institute, University of California Los Angeles, CA, USA Abstract: Myopic choroidal neovascul...
Main Authors: | Tan CS, Sadda SR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-09-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/anti-vascular-endothelial-growth-factor-therapy-for-the-treatment-of-m-peer-reviewed-article-OPTH |
Similar Items
-
Myopic Choroidal Neovascularization Membranes Treated With Ranibizumab in Colombian Population
by: Hernan Andres Rios, et al.
Published: (2017-01-01) -
Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes
by: Meng-Tian Kang, et al.
Published: (2024-03-01) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01) -
Role of optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal injections of Ranibizumab
by: Meng Cai, et al.
Published: (2017-10-01) -
ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
by: S. A. Korotkikh, et al.
Published: (2016-11-01)